137 related articles for article (PubMed ID: 19005937)
1. Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma.
Li Q; Wang Y; Feng N; Fan Z; Sun J; Nan Y
J Drug Target; 2008 Dec; 16(10):725-32. PubMed ID: 19005937
[TBL] [Abstract][Full Text] [Related]
2. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
3. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
4. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
Xu J; Zhao JH; Liu Y; Feng NP; Zhang YT
Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles].
Zhao J; Liu Z; Xu J; Yu Y; Feng N
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
[TBL] [Abstract][Full Text] [Related]
7. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
8. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
9. [Study on the pharmacokinetics of tashinone II(A) -loaded polylactic acid nanoparticles in rabbit].
Wang Y; Feng NP; Nan YL; Zhong LH; Chen HY; Fan ZZ; Li Q
Zhong Yao Cai; 2011 Sep; 34(9):1392-5. PubMed ID: 22260008
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
Wang Y; Song D; Costanza F; Ji G; Fan Z; Cai J; Li Q
J Biomed Nanotechnol; 2014 Nov; 10(11):3244-52. PubMed ID: 26000384
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
13. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
Zhang X; Liu L; Chai G; Zhang X; Li F
Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
[TBL] [Abstract][Full Text] [Related]
14. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
15. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
Xing J; Zhang D; Tan T
Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of two preparation methods applied in tanshinone II(A)-loaded PLGA nanoparticles].
Gan LC; Hou SX; Bi YQ; Wang CG; Wang XC; Chen QX
Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(7):578-81. PubMed ID: 17583194
[TBL] [Abstract][Full Text] [Related]
17. Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.
Bi HC; Zuo Z; Chen X; Xu CS; Wen YY; Sun HY; Zhao LZ; Pan Y; Deng Y; Liu PQ; Gu LQ; Huang ZY; Zhou SF; Huang M
Xenobiotica; 2008 Feb; 38(2):185-222. PubMed ID: 18197559
[TBL] [Abstract][Full Text] [Related]
18. Biosurfactant stabilized anticancer biomolecule-loaded poly (D,L-lactide) nanoparticles.
Kumar V; Kumari A; Kumar D; Yadav SK
Colloids Surf B Biointerfaces; 2014 May; 117():505-11. PubMed ID: 24581629
[TBL] [Abstract][Full Text] [Related]
19. A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles.
Cui F; Li Y; Zhou S; Jia M; Yang X; Yu F; Ye S; Hou Z; Xie L
Nanoscale Res Lett; 2013 Jun; 8(1):301. PubMed ID: 23806106
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
Liu M; Li H; Luo G; Liu Q; Wang Y
Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
